Skip to content

RxSight, Inc. RXST Inventories

Inventories at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$14.58B+15.2%
LENSAR, Inc. logo
LENSAR, Inc.LNSR
$23.1M+50.7%
Ocular Therapeutix logo
Ocular TherapeutixOCUL
$3.74M+14.3%
Precision Optics Corporation logo
Precision Optics CorporationPOCI
$3.7M+0.8%
Bausch + Lomb logo
Bausch + LombBLCO
$977M-5.2%
Glaukos logo
GlaukosGKOS
$62.38M+4.9%

Other financials

Income statement

See full
Revenue$30.9M-18.5%
Gross profit$23.5M-17.1%
Operating income-$17.8M-67.0%
Net income-$15.9M-93.9%
EPS (diluted)-$0.38-90.0%

Balance sheet

See full
Cash & equivalents$17.6M-37.2%
Total debt$10.8M-10.1%
Total equity$267.3M-4.3%
Total assets$304.0M-2.9%

Cash flow

See full
Operating cash flow-$10.9M-23.3%
CapEx$759.0K+32.0%
Free cash flow-$11.7M-23.8%

Valuation

See full
Market cap$232.23M-56.8%
Enterprise value$225.49M-55.7%
P/S1.8×-1.8×

Profitability

See full
Gross margin77%+5.1pp
Operating margin-43.4%+128pp
Net margin-36.6%-867pp
FCF margin-16.9%+4.9pp

Returns & leverage

See full
Return on equity-17.1%+12.6pp
Debt / equity0.0×
Current ratio10.2×-2.5×

Where this comes from

Reported directly by RxSight, Inc. in its filing.

Tagged under the XBRL concept us-gaap:InventoryNet.

The official record: RxSight, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about RxSight, Inc.'s inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is RxSight, Inc.'s inventories?
RxSight, Inc. (RXST) reported inventories of $34.87M in Q1 2026.
How has RxSight, Inc.'s inventories changed year-over-year?
RxSight, Inc.'s inventories increased by 47.9% year-over-year, from $23.57M to $34.87M.
What is the long-term trend for RxSight, Inc.'s inventories?
Over 4 years (2021 to 2025), RxSight, Inc.'s inventories has grown at a 41.2% compound annual growth rate (CAGR), from $27.48M to $109.14M.
What does inventories mean?
Total inventory including raw materials, work-in-progress, and finished goods, valued at the lower of cost or net realizable value.